ACTonCancer: feasibility and effectiveness of an internet- and mobile-based acceptance and commitment therapy for cancer patients - a randomized controlled pilot study

ACTonCancer: feasibility and effectiveness of an internet- and mobile-based acceptance and commitment therapy for cancer patients - a randomized controlled pilot study - ACTonCancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013195

Enrollment

Registered

2017-10-19

Start date

2017-10-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Participants in the intervention group will have unrestricted access to all medical and psychological offers of the health care system (standard care). Additionally, they will get access to a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Cancer diagnosis, age >= 18 years, access to the internet, german literacy

Exclusion criteria

Exclusion criteria: medical objections

Design outcomes

Primary

Measure	Time frame
Feasibility: there are two measurements, respectively (T1: before randomisation and T2: 8 weeks post randomisation). Process-related: Recruitment (strategies and figures), questions due to satisfaction with contents after each session Time of measurement: Drop-out rate (T2), acceptance (questionnaire APOI (T1, T2),), adverse events (questionnaire INEP) (T1,T2)	—

Secondary

Measure	Time frame
All outcomes will be assessed by self-report at T1: before randomisation and T2: 8 weeks post randomisation; cancer-related distress (distress thermometer; T1, T2), quality of life (EORTC QLQ-C30; T1, T2), Depression (PHQ-9; T1, T2), Anxiety (GAD-7; T1, T2), fear of progression (PA-F-KF; T1, T2), pain (BPI; T1, T2), fatigue (11-item FQ; T1, T2), psychological flexibility (FAH-II; T1, T2), spiritual well-being (FACIT-Sp 12; T1, T2)	—

Measure

Time frame

All outcomes will be assessed by self-report at T1: before randomisation and T2: 8 weeks post randomisation; cancer-related distress (distress thermometer; T1, T2), quality of life (EORTC QLQ-C30; T1, T2), Depression (PHQ-9; T1, T2), Anxiety (GAD-7; T1, T2), fear of progression (PA-F-KF; T1, T2), pain (BPI; T1, T2), fatigue (11-item FQ; T1, T2), psychological flexibility (FAH-II; T1, T2), spiritual well-being (FACIT-Sp 12; T1, T2)

—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactNatalie Bauereiß

Abteilung für kKinische Psychologie und Psychotherapie, Institut für Psychologie undPädagogik,Universität Ulm

natalie.bauereiss@uni-ulm.de+49 (0) 731 5032808

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026